Hope restored: The critical role that Minimal Residual Disease can play in blood cancer patient care

Adaptive is dedicated to recognizing patients like Tiffany and to contribute to the world’s understanding of the critical role that MRD can play in blood cancer patient care.
Among Multiple Myeloma Patients Receiving MRD Testing, Majority Report Meaningful Benefits

MRD testing can help to provide an accurate, ongoing picture of disease and risk status, offering a sense of control and comfort during a time when life may feel less manageable.
SPIN Girls Field Day Retrospective

As a lifelong conservationist and advocate for responsible consumption, for me, bringing my whole self to work means these passions come to the office with me.
Introducing Sustainability @ Adaptive

As a lifelong conservationist and advocate for responsible consumption, for me, bringing my whole self to work means these passions come to the office with me.
The Adaptive Internship Experience: A Perspective from Sydney W

During my time at Adaptive, I came to learn the inextricable connection between clinical medicine, biotechnological advancement, and the patient story.
A Message from Co-Founder and CEO Chad Robins

In this video Barbara Zehentner (VP, Molecular Lab Operations), Mark Adams (Chief Operating Officer), John Alsobrook (Sr. Clinical Lab Director), and our laboratory staff introduce you to the heartbeat of Adaptive Biotechnologies: our Molecular Laboratory Operations.
Molecular Laboratory Operations: The Heartbeat of Adaptive

In this video Barbara Zehentner (VP, Molecular Lab Operations), Mark Adams (Chief Operating Officer), John Alsobrook (Sr. Clinical Lab Director), and our laboratory staff introduce you to the heartbeat of Adaptive Biotechnologies: our Molecular Laboratory Operations.
Whatever Happens, the Patient Has to be at the Center

Biology and technology are converging in amazing ways, helping us to make remarkable headway against serious diseases every single day.
It’s more than a number: Pride co-leader Shay Miller on the impact of Adaptive’s high marks on the HRC Corporate Equality Index

Biology and technology are converging in amazing ways, helping us to make remarkable headway against serious diseases every single day.
Adaptive Computational Biologist Rachel Gittelman on her 2021 STAT Wunderkind Induction

Biology and technology are converging in amazing ways, helping us to make remarkable headway against serious diseases every single day.